Just over a month after crossing the T's on a $535 million acquisition by Cubist Pharmaceuticals ($CBST), Optimer Pharmaceuticals is shedding 177 jobs in the U.S. and Canada, New Jersey's Star-Ledger reports. Massachusetts-based Cubist is shutting down Optimer's Garden State headquarters next year, according to the newspaper, and the company is working with affected employees to see if they might fit in elsewhere in its operations. Report